Gilead Sciences, Inc.

Q4 2016 vs. Q2 2020 13F Holders

Period
Q4 2016
Q2 2020
Num holders
1,694
1,735
Total reported value, excl. options
$71.8 B
$77.2 B
Total shares, excl. options
1,001,888,916
996,599,706
Manager Q4 2016
Shares 		Q2 2020
Shares 		Diff Chg %